참고문헌
- A. Watanabe, T. Hanawa and M. Suginara, Application of Glycerogelatin as oral dosage form for the elderly, Yakuzaigaku, 54, 77-87 (1994)
- T. Hanawa, A. Watanabe, T. Tsuchiya, R. Ikoma, M. Hidaka and M. Sugihara, New oral dosage form for elderly patients: preparation and characterization of silk fibroin gel. Chem. Pharm. Bull., 43, 284-288 (1995) https://doi.org/10.1248/cpb.43.284
- M. T. Maya, N. J. Goncalves, N. E. Silva, A. E. Filipe, J. A. Morais, M.C. Caturla and M. Rovira, Comparative bioavailability of two immediate release tablets of enalapril/hydrochlorothiazide in healthy volunteers, Eur. J. Drug Metab. Pharmacokinet., 27, 91-99 (2002) https://doi.org/10.1007/BF03190422
- M. Lohitnavy, O. Lohitnavy, S. Wittaya-areekul, K. Sareekan, S. Polnok and W. Chaiyaput. Average bioequivalence of clarithromycin immediate released tablet formulations in healthy male volunteers, Drug Dev. Ind Pharm., 29, 653-659 (2003) https://doi.org/10.1081/DDC-120021314
- J. Carpay, J. Schoenen, F. Ahmad, F. Kinrade and D. Boswell, Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study, Clin. Ther., 26, 214-223 (2004) https://doi.org/10.1016/S0149-2918(04)90020-3
- G. H. Junnarkar and S. Stavchansky, Isothermal and nonisothermal decomposition of famotidine in aqueous solution, Pharm. Res., 12, 599-604 (1995) https://doi.org/10.1023/A:1016222501079
- V. Mummaneni and R. C. Vasavadam, Solubilization and dissolution of famotidine from solid glass dispersions of xylitol, Int. J. Pharm., 66, 71-77 (1990) https://doi.org/10.1016/0378-5173(90)90386-I
- M. A. Hassan, M. A. Suleiman and N. M. Najib, Imrpovement of the in vitro dissolution characteristics of famotidine by inclusion in beta-cyclodextrin, Int. J. Pharm., 58, 19-24 (1990) https://doi.org/10.1016/0378-5173(90)90282-9
- M. S. Islam and M. M. Narurkar, Effect of 2-hydroxypropylbeta-cyclodextrin on the solubility, stability and dissolution rate of famotidine, Drug Dev. Ind Pharm., 17, 1229-1239 (1991) https://doi.org/10.3109/03639049109043856
- F. Hirayama, Z. Wang and K. Uekama, Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid state, Pharm. Res., 11, 1766-1770 (1994) https://doi.org/10.1023/A:1018971501909
- Y. Bi, H. Sunada, Y. Yonezawa, K. Danjo, A. Otsuka and K. Iida, Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity, Chem. Pharm. Bull. (Tokyo), 44,2121-2127 (1996) https://doi.org/10.1248/cpb.44.2121
- G Abdelbary, P. Prinderre, C. Eouani, J. Joachim, J. P. Reynier and Ph. Piccerelle, The preparation of oraaly disintegrating tablets using a hydrophilic waxy binder, Int. J. Phar., 278, 423-433 (2004) https://doi.org/10.1016/j.ijpharm.2004.03.023
- J. Fukami, E. Yonemochi, Y. Yoshihashi and K. Terada, Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose, Int. J. Pharm., 310, 101-109 (2006) https://doi.org/10.1016/j.ijpharm.2005.11.041
- Y. Watanabe, T. Ishikawa, B. Mukai, S. Shiraishi, N. Utoguchi, M. Fujii and M. Matsumoto, New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Bio. Pharm. Bull., 18,1308-1310 (1995) https://doi.org/10.1248/bpb.18.1308
- Y. Bi, Y. Yorinobu and H. Sunada, Rapidly disintegrating tablets prepared by wet compression method: mechanism and optimization. J. Pharm. Sci., 88, 1004-1010 (1999) https://doi.org/10.1021/js990061z
- H. Sunada and Y. Bi, Preparation, evaluation and optimization of rapidly disintegrating tablets, Powder Technol., 122, 188198 (2002) https://doi.org/10.1016/S0032-5910(01)00415-6
- R. K. Chang, X. Guo, B. Burnside and R. Couch, Fast-Dissolving Tablets, Pharm. Technol., 24, 52-58 (2000)
- T. Mizumoto, Y. Masuda, and M. Fukui, Intrabuccally dissolving compressed mouldings and production process thereof. US Patent 5 576 014 (1996)
- K. Muraoka and M. Fukui, Granules for the preparation of fast disintegrating and fast dissolving compositions containing a high amount of drug. US Patent 0 058 372 9/2A (1996)